Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Fundamental Science, Translational Research, Clinical Research, Workforce
Hematology Disease Topics & Pathways:
Fundamental Science, Translational Research, Clinical Research, Workforce
Sunday, December 8, 2024: 4:30 PM-6:00 PM
Room 24
(San Diego Convention Center)
Chairs:
Juan Pablo Alderuccio, MD, Sylvester Comprehensive Cancer Center University of Miami
and
Shruti Chaturvedi, MBBS, Johns Hopkins University
Disclosures:
Alderuccio: Regeneron: Consultancy; Genmab: Research Funding; BeiGene: Research Funding; AbbVie: Consultancy; ADC Therapeutics: Consultancy, Research Funding; Genentech: Consultancy. Chaturvedi: Takeda: Consultancy, Membership on an entity's Board of Directors or advisory committees; Sanofi: Consultancy, Membership on an entity's Board of Directors or advisory committees; Alexion, AstraZeneca Rare Disease: Consultancy, Membership on an entity's Board of Directors or advisory committees; SOBI: Consultancy, Membership on an entity's Board of Directors or advisory committees.
This symposium aims to guide the audience through the common challenges faced by mid-career hematologists. Some examples of unique challenges for mid-career hematologists include negotiating the first leadership position, principles of leadership, promotion, strategies for managing individuals and teams, conflict management, setting up a successful research program, time management, funding beyond career development awards, performance and compensation metrics, self-care and opportunities to contribute to the Society’s mission. Speakers will include a diverse pool of successful physicians and scientists from academia, regulatory agencies, and the pharmaceutical industry. It is envisioned that this educational session will be organized by a steering committee of Society members who will identify a longitudinal curriculum for the session and speakers and topics.
See more of: Special-Interest Sessions